The role of insulin sensitising agents in polycystic ovary syndrome

Harborne, Lyndal Ruth (2005) The role of insulin sensitising agents in polycystic ovary syndrome. MD thesis, University of Glasgow.

Full text available as:
[img]
Preview
PDF
Download (6MB) | Preview

Abstract

Polycystic Ovary Syndrome (PCOS) is a common disorder of chronically abnormal ovarian function and hyperandrogenism whose clinical effects include oligomenorrhoea and hirsutism. It has been determined that the principal underlying defect is hyperinsulinaemia secondary to insulin resistance. Use of insulin sensitising agents in women with PCOS is becoming increasingly widespread. Trials with metformin, one such agent, enthusiastically report a wide range of benefits in metabolic, reproductive and clinical measures. We have shown that metformin treatment of women with polycystic ovary syndrome has the following effects; o It may be more effective than Dianette in the treatment of hirsutism. o It is effective in reducing weight and improves lipid profiles in obese women with oligomenorrhea or a raised free androgen index. o It reduces serum mullerian inhibiting substance in the circulation after protracted treatment (> 4months). o It has effects upon adrenal androgen biosynthesis manifested by a reduction in circulating basal concentrations of 170HP.

Item Type: Thesis (MD)
Qualification Level: Doctoral
Additional Information: Adviser: Jane Norman
Keywords: Immunology
Date of Award: 2005
Depositing User: Enlighten Team
Unique ID: glathesis:2005-71489
Copyright: Copyright of this thesis is held by the author.
Date Deposited: 17 May 2019 09:31
Last Modified: 17 May 2019 09:31
URI: http://theses.gla.ac.uk/id/eprint/71489

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year